Recent News

Share
and/or
Upcoming Seminars and Events

View upcoming seminars and events.

Learn more
18 News Items found
In the Lab
An origami crane illustrates the importance of RNA folding for regulating gene translation. The bolded sequences on the crane’s wings indicate the portion that is critical for the manufacture of many cancer-causing proteins.
Compound from Tropical Plant Targets Key Cancer-Causing Genes

Memorial Sloan Kettering researchers have found a naturally occurring compound that can destroy cancer cells in mice by targeting <em>MYC</em>, a cancer-causing gene that has remained elusive until now.
In the Clinic
New Trial Advances Cell-Based Immune Therapy for Certain Leukemias

A new study evaluating a cell-based immune therapy to treat an aggressive type of leukemia — the largest study of its kind to date — reports that 88 percent of patients responded to the treatment.
In the News
New Biotech Startup Will Pit the Immune System Against Cancer

Memorial Sloan Kettering’s partnership in a pioneering effort to speed the development of cancer immunotherapies drew national headlines.
In the Lab
Pictured: Kenneth Offit
Gene Mutation Linked to Inherited Risk of Common Form of Childhood Leukemia

Researchers have found the first evidence that susceptibility to developing acute lymphoblastic leukemia during childhood may be heritable.
In the Clinic
Cell-Based Immune Therapy Shows Promise in Leukemia Patients

Memorial Sloan Kettering researchers have used genetically modified immune cells to eradicate cancer in five patients with acute lymphoblastic leukemia.
In the Lab
Pictured: ESK1 Monoclonal Antibody
New Molecule Targets Proteins Inside Cancer Cells

Scientists from Memorial Sloan Kettering have collaborated on the discovery of a unique monoclonal antibody, called ESK1, that appears to be effective at targeting and destroying several types of cancer cells.
In the Lab
Pictured: Natural Killer Cells & Cancer Cell
Study Suggests Refined Donor Selection Could Improve Outcomes of Bone Marrow Transplantation in Leukemia

In the future, more-advanced genetic testing might offer better ways to match up patients who need a bone marrow transplant with potential donors.
Profile
Pictured: Hans-Guido Wendel
Genetic Causes of Blood Cancers Explored

German-born cancer biologist Hans-Guido Wendel is taking advantage of transformative advances in genomics technology to understand key genetic abnormalities in leukemia and lymphoma.